AHA 2019
Advertisement
The results of a new study suggest that the use of Impella is associated with worse outcomes compared to Intra-Aortic ...
Findings from a new study presented at the American Heart Association 2019 Scientific Sessions in Philadelphia may ...
The use of colchicine can reduce inflammation during percutaneous coronary intervention (PCI), according to the findings ...
Female veterans with posttraumatic stress disorder (PTSD) incur more risk factors associated with heart disease, such as ...
Patients with return of spontaneous circulation (ROSC) after following out-of-hospital cardiac arrest (OHCA) without ...
Icosapent ethyl was effective at slowing coronary atherosclerosis, according to new study results presented at the ...
Researchers have developed diabetes mellitus (DM)-specific risk score that demonstrates efficacy in assessing the risk ...
There is a troubling upward trend of heart arrhythmias and acute myocardial infarctions (AMIs), especially in young male ...
Dapagliflozin is an effective treatment for patients with heart failure with reduced ejection fraction (HFrEF) across ...
The use of methamphetamine (meth) can cause severe heart failure (HF) but stopping use can significantly improve ...
New study results presented at the American Heart Association 2019 Scientific Sessions in Philadelphia suggest that an ...
Rivaroxaban-based antithrombotic strategy was more effective at preventing some leaflet thickening and leaf motion than ...
Early surgery appears a better option than conventional management among asymptomatic patients with severe aortic ...
Two of the most widely used transcatheter heart valves (THV) designs may not achieve the same clinical outcomes, ...
New research from the American Heart Association Scientific Sessions 2019 in Philadelphia suggest that different future ...
The daily use of colchicine significantly reduces the risk of first and total ischemic cardiovascular (CV) events ...
The use inclisiran reduces low-density lipoprotein (LDL-C) levels in patients with atherosclerotic cardiovascular ...
The findings of the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) suggest that ...
A study called the BETonMACE trial, which was presented at the American Heart Association’s Scientific Sessions 2019, ...
The findings of a new study suggest that individuals who have survived heart attacks have an increased risk of ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.